Stockscreener 앱 받기
36.12
1.91%
-0.705
시장 영업 전:
36.26
0.135
+0.37%
Tg Therapeutics Inc 주식(TGTX)의 최신 뉴스
Detecting support and resistance levels for TG Therapeutics Inc.2025 Risk Factors & Smart Money Movement Alerts - newser.com
What TG Therapeutics, Inc.'s (NASDAQ:TGTX) 26% Share Price Gain Is Not Telling You - simplywall.st
Key metrics from TG Therapeutics Inc.’s quarterly dataProfit Target & Fast Gain Swing Trade Alerts - newser.com
Can TG Therapeutics Inc. stock rebound after recent weakness2025 Market Sentiment & AI Optimized Trade Strategies - newser.com
What indicators show strength in TG Therapeutics Inc.Exit Point & Consistent Return Investment Signals - newser.com
Is TG Therapeutics Inc. forming a bottoming base2025 Analyst Calls & Long-Term Safe Investment Plans - newser.com
What makes TG Therapeutics Inc. (NKB2) stock appealing to growth investorsEntry Point & Low Risk Entry Point Tips - newser.com
Analyzing TG Therapeutics Inc. with risk reward ratio chartsJuly 2025 Earnings & Capital Efficiency Focused Ideas - newser.com
TG Therapeutics, Inc. (TGTX) Investor Outlook: Strong Revenue Growth and Promising Pipeline Signal Potential Upside - DirectorsTalk Interviews
TG Therapeutics, Inc. (TGTX) Investor Outlook: Riding On A 92.10% Revenue Growth Wave - DirectorsTalk Interviews
TG Therapeutics (TGTX) Slashes 18% on Lower 2025 Sales Guidance - MSN
What drives TG Therapeutics Inc stock priceGlobal Trade Effects & Low Risk Capital Growth Plans - earlytimes.in
Is TG Therapeutics Inc a good long term investmentHead and Shoulders Patterns & Demo Trading Rooms Open Daily - Early Times
What analysts say about TG Therapeutics Inc stockStock Valuation Metrics & Backtest Your Strategy Before You Risk Money - earlytimes.in
How risky is TG Therapeutics Inc. (NKB2) stock compared to peers2025 Historical Comparison & Advanced Swing Trade Entry Plans - newser.com
Tg Therapeutics And Ke Holdings Top The Bull Strangle Watch List For This Week - Barchart.com
TG Therapeutics’ MS drug shows low relapse rate after six years By Investing.com - Investing.com South Africa
TG Therapeutics’ MS drug shows low relapse rate after six years - Investing.com India
TGTX Shares Rise on Promising Six-Year Data from ULTIMATE Trials - GuruFocus
TG Therapeutics Says 6-Year Briumvi Data Show 90% of Multiple Sclerosis Patients Free From Progression - MarketScreener
TG Therapeutics Reports Six-Year Data for BRIUMVI® Showing Exceptional Efficacy and Consistent Safety Profile in Multiple Sclerosis Treatment - Quiver Quantitative
New Data for BRIUMVI® Demonstrate 89.9% of Patients with - GlobeNewswire
Breakthrough: MS Drug Keeps 90% of Patients Disability-Free for 6 YearsTG Therapeutics' BRIUMVI Sets New Bar - Stock Titan
TG Therapeutics Hits Day High with Strong 8.03% Intraday Surge - Markets Mojo
19,900 Shares in TG Therapeutics, Inc. $TGTX Bought by Strs Ohio - MarketBeat
TG Therapeutics (TGTX): Evaluating Valuation After New Phase 3 BRIUMVI Trial Launch - Sahm
What is B. Riley's Estimate for TG Therapeutics Q3 Earnings? - MarketBeat
TG Therapeutics (NASDAQ:TGTX) Price Target Raised to $55.00 - MarketBeat
TG Therapeutics, Inc. (NASDAQ:TGTX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Bull Run: Can TG Therapeutics Inc maintain sales growthMarket Growth Summary & Low Risk Profit Maximizing Plans - خودرو بانک
Strs Ohio Makes New Investment in TG Therapeutics, Inc. $TGTX - Defense World
What is B. Riley's Estimate for TG Therapeutics Q4 Earnings? - MarketBeat
Voya Investment Management LLC Has $11.85 Million Position in TG Therapeutics, Inc. $TGTX - MarketBeat
What is B. Riley’s Forecast for TG Therapeutics Q4 Earnings? - Defense World
Day Trade: Will TG Therapeutics Inc outperform tech stocksWeekly Trend Report & Weekly Stock Breakout Alerts - خودرو بانک
Short Squeeze: Should you avoid ProShares Trust ProShares Ultra Materials stock right now2025 Volume Leaders & Reliable Volume Spike Trade Alerts - khodrobank.com
B. Riley Has Bearish Outlook for TG Therapeutics Q3 Earnings - Defense World
Market Review: What are TG Therapeutics Incs recent SEC filings showingEarnings Overview Report & Daily Entry Point Alerts - khodrobank.com
Institution Moves: Does TG Therapeutics Inc stock benefit from AI growth2025 Fundamental Recap & Weekly Return Optimization Alerts - khodrobank.com
TG Therapeutics (NASDAQ:TGTX) Price Target Raised to $55.00 at B. Riley - Defense World
Intech Investment Management LLC Increases Stock Holdings in TG Therapeutics, Inc. $TGTX - MarketBeat
Sentiment Review: Can TG Therapeutics Inc. sustain its profitabilityWeekly Investment Recap & AI Forecast for Swing Trade Picks - khodrobank.com
TG Therapeutics rises 17% as 2025 revenue guidance, Q4 revenue beats expectations - MSN
TGTX: B. Riley Securities Raises Price Target on TG Therapeutics - GuruFocus
How cyclical is TG Therapeutics Inc.’s revenue streamWeekly Stock Recap & Free Risk Controlled Daily Trade Plans - خودرو بانک
B. Riley Raises Price Target on TG Therapeutics to $55 From $53, Keeps Buy Rating - MarketScreener
Focus Partners Wealth Boosts Stock Holdings in TG Therapeutics, Inc. $TGTX - Defense World
Quarterly Trades: Is TG Therapeutics Inc undervalued by DCF analysis2025 Macro Impact & Weekly High Return Stock Forecasts - خودرو بانک
TG Therapeutics (NASDAQ:TGTX) Director Sagar Lonial Sells 20,852 Shares - MarketBeat
Bull Bear: Is Urgent.ly Inc. a potential multi baggerRate Hike & Daily Profit Maximizing Tips - خودرو بانک
Will TG Therapeutics Inc benefit from AI trends2025 Key Lessons & Weekly High Return Stock Forecasts - خودرو بانک
Weekly Earnings: Can TG Therapeutics Inc maintain sales growth2025 Trade Ideas & AI Driven Price Forecasts - khodrobank.com
Woodline Partners LP Makes New Investment in TG Therapeutics, Inc. $TGTX - MarketBeat
Signal Recap: Is TG Therapeutics Inc. currently under institutional pressureJuly 2025 Intraday Action & Trade Opportunity Analysis Reports - khodrobank.com
Aug Macro: How cyclical is TG Therapeutics Incs revenue streamJuly 2025 Selloffs & Reliable Momentum Entry Alerts - خودرو بانک
2.36%
1.10%
자본화:
|
볼륨(24시간):